Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.56 -0.01 (-1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tenaya Therapeutics (TNYA) Non-Current Deffered Revenue (2026)

Updated

Tenaya Therapeutics (TNYA) posted Non-Current Deffered Revenue of $3.94 million for Q2 2026, down 15.9% from the prior quarter.

Analysis

Tenaya Therapeutics (TNYA) Non-Current Deffered Revenue (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Tenaya Therapeutics 125.57 Mn 125.57 Mn - 3.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.94 Mn
Mar 31, 2026 4.68 Mn
API Access

Tenaya Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TNYA&period=max&api_key=YOUR_API_KEY